For this year Coloplast's revenue will be around 17,92 billion Danish Krone. This is according to the average of the analysts' estimates. This is slightly more than 2018's revenue of 16,45 billion Danish Krone.
The analysts expect for 2019 a net profit of 4,24 billion Danish Krone. The majority of the analysts expects for this year a profit per share of 19,97 Danish Krone. The price-earnings-ratio equals 41,18.
Per share the analysts anticipate on a dividend of 16,89 Danish Krone per share. Thus the dividend yield equals 2,05 percent. The average dividend yield of the pharmaceutical companies equals an attractive 4 percent.
Coloplast's market capitalization is based on the number of outstanding shares around 159,7 billion Danish Krone. The Coloplast stock was the past 12 months quite unstable. Since last November the stock is even 38 percent higher. This year the stock price moved between 585 and 851 DKK.
Click here for dividend . At 10.50 the stock trades 1,05 percent lower at 822,4 Danish Krone.
Analist.nl Nieuwsdienst: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.